Investor letter: Thrive's 2022 early-stage $516M fund that invested in OpenAI and SpaceX was worth $3.7B+ as of the end of June, net of fees and other charges
Investor letter: Thrive's 2022 early-stage $516M fund that invested in OpenAI and SpaceX was worth $3.7B+ as of the end of June, net of fees and other charges
Google invests in independent movie studio A24 as part of a new AI partnership; sources say Google is investing ~$75M, roughly equal to Thrive's 2024 investment
Search giant is putting about $75 million into the film company as part of an artificial-intelligence research partnership
Google invests in independent movie studio A24 as part of a new AI partnership; sources say Google is investing ~$75M, roughly equal to Thrive's 2024 investment
Search giant is putting about $75 million into the film company as part of an artificial-intelligence research partnership
NYC-based Pace, whose AI agents automate back-office operations for insurance companies, raised a $46M series B led by Thrive and Sequoia at a $375M valuation
NYC-based Pace, whose AI agents automate back-office operations for insurance companies, raised a $46M series B led by Thrive and Sequoia at a $375M valuation
The startup says its AI agents can handle the dull work insurers have long shipped to offshore operators.
Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025
Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …
Anduril raised a $5B Series H led by Thrive and a16z at a $61B valuation, up from $30.5B in June 2025, taking its total funding to $6.82B, and could IPO in 2027
The start-up, which makes A.I.-backed weapons, was valued at $61 billion in the financing round, double what it was a year ago.
Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025
Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …
Thrive is taking a stake in the San Francisco Giants via a new venture that will invest in franchises and cultural institutions that can't be replicated by AI
It's the first investment from the firm's new strategy focused on long-term investments in franchises and cultural institutions that can't be replicated by AI